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The role of the amino and carboxyl-terminal regions of cytosolic serine hydroxymethyltransferase 
(SHMT) in subunit assembly and catalysis was studied using six amino-terminal (lacking the first 6, 14, 
30, 49, 58, and 75 residues) and two carboxyl-terminal (lacking the last 49 and 185 residues) deletion 
mutants. These mutants were constructed from a full length cDNA clone using restriction enzyme/PCR- 
based methods and overexpressed in Escherichia coli. The overexpressed proteins, des-(A1 - K6)-SHMT 
and des-(A1 - W14)-SHMT were present in the soluble fraction and they were purified to homogeneity. 
The deletion clones, for des-(A1 -V30)-SHMT and des-(A1 -L49)-SHMT were expressed at very low 
levels, whereas des-(A1 -R58)-SHMT, des-(A1 -G75)-SHMT, des-(Q435 -F483)-SHMT and des- 
(L299 -F483)-SHMT mutant proteins were not soluble and formed inclusion bodies. Des-(A1 - K6)- 
SHMT and des-(A1 - W14)-SHMT catalyzed both the tetrahydrofolate-dependent and tetrahydrofolate- 
independent reactions, generating characteristic spectral intermediates with glycine and tetrahydrofolate. 
The two mutants had similar kinetic parameters to that of the recombinant SHMT (rSHMT). However, 
at 55"C, the des-(Al-W14)-SHMT lost almost all the activity within 5 min, while at the same temper- 
ature rSHMT and des-(A1 -K6)-SHMT retained 85 % and 70% activity, respectively. Thermal denatur- 
ation studies showed that des-(A1 - W14)-SHMT had a lower apparent melting temperature (52 "C) com- 
pared to rSHMT (56°C) and des-(A1 -K6)-SHMT (55 "C), suggesting that N-terminal deletion had re- 
sulted in a decrease in the thermal stability of the enzyme. Further, urea induced inactivation of the 
enzymes revealed that 50% inactivation occurred at a lower urea concentration (1.2-CO.l M) in the case 
of des-(Al-W14)-SHMT compared to rSHMT (1.8?0.1 M) and des-(Al-K6)-SHMT (1.7-C0.1 M). 
The apoenzyme of des-(Al-W14)-SHMT was present predominantly in the dimer form, whereas the 
apoenzymes of rSHMT and des-(Al-K6)-SHMT were a mixture of tetramers ( ~ 7 5 %  and =65%, re- 
spectively) and dimers. While, rSHMT and des-(A1 - K6)-SHMT apoenzymes could be reconstituted 
upon the addition of pyridoxal-5'-phosphate to 96 % and 94 % enzyme activity, respectively, des-(A1 - 
W14)-SHMT apoenzyme could be reconstituted only upto 22 %. The percentage activity regained corre- 
lated with the appearance of visible CD at 425 nm and with the amount of enzyme present in the tetra- 
meric form upon reconstitution as monitored by gel filtration. These results demonstrate that, in addition 
to the cofactor, the N-terminal arm plays an important role in stabilizing the tetrameric structure of SHMT. 
Keywords: sheep cytosolic serine hydroxymethyltransferase ; N-terminal deletion mutant; C-terminal de- 
letion mutant; overexpression; subunit assembly. 
Serine hydroxymethyltransferase (SHMT), a pyridoxal-5'- 
phosphate (pyridoxal-P)-dependent enzyme, plays a crucial role 
in one-carbon metabolism and provides precursors for the bio- 
synthesis of purines, thymidylate, methionine, etc. [ 11. The 
physiological reaction catalyzed by this enzyme is the reversible 
conversion of serine and 5,6,7&tetrahydrofolate (H,-folate) to 
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Abbreviations. SHMT, serine hydroxymethyltransferase; H,-folate, 
5,6,7,8-tetrahydrofolate; pyridoxal-P, pyridoxal 5'-phosphate; pyridox- 
mine? ,  pyridoxamine 5'-phosphate; rSHMT, sheep liver cytosolic re- 
combinant SHMT; AAT, aspartate aminotransferase ; buffer A, 50 mM 
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Enzymes. Serine hydroxymethyltransferase (EC 2.1.2.1) ; aspartate 
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glycine and 5,10-methylene-H4-folate. The enzyme exhibits 
broad substrate and reaction specificity [2]. The mammalian cy- 
tosolic enzyme is a tetramer of identical subunits of 53 kDa with 
4 mol pyridoxal-P/mol enzyme [3]. The sheep liver cytosolic 
enzyme has been extensively characterized in our laboratory 
with respect to its primary structure [4], catalysis [5,  61, thermal 
stability [7] and interaction with inhibitors [8- 101. This enzyme 
has been cloned and overexpressed in Escherichia coli [ l l ] .  Re- 
cently, it has been shown that pyridoxal-P has an important role 
in the stabilization of quaternary structure [12]. 
In pyridoxal-P-dependent enzymes, limited proteolysis re- 
sults in the formation of a core protein devoid of N-terminus 
which is either partially active [13], inactive [I41 or fully active 
[15, 161. In the case of porcine cytosolic aspartate aminotrans- 
ferase (AAT), the deletion of nine amino acids from the amino- 
terminus by oligonucleotide-directed mutagenesis resulted in a 
striking decrease in its activity and thermal stability [17]. The 
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N-terminal region was shown to play a role in the inter-subunit 
interactions of porcine cytosolic AAT [17]. It was evident from 
the crystallographic data that several pyridoxal-P-requiring en- 
zymes have the same spatial fold as AAT even though these 
proteins have less than 15% sequence identity [18-201. 
The alignment of SHMT sequences from several sources re- 
vealed that the N- and C-termini were less conserved compared 
to rest of the protein [4]. It was therefore of interest to examine 
the role of these terminal regions of the protein on its structural 
and functional properties. By limited proteolytic digestion, it 
was shown that the N-terminal 15 residues may not be important 
for the catalytic activity ([16] and Bhaskar et al., unpublished 
results). A disadvantage of the partial proteolysis procedure is 
the difficulty in obtaining pure preparations of the truncated pro- 
tein as the cleaved peptides often associate non-covalently with 
the core molecule. To circumvent this problem, we decided to 
generate the deletions at 5’ and 3‘ ends of the cDNA clone of 
SHMT and express these deletion clones. In this paper, we report 
the construction, expression, purification, characterization of de- 
letion mutants of the sheep liver cytosolic SHMT and also show 
the importance of N-terminal arm in the stabilization of the di- 
mer - dimer interactions which are crucial for tetramer formation 
and cofactor binding. 
EXPERIMENTAL PROCEDURES 
Materials. [a-3ZP]dATP (3000 Ci/mmol) and ~-[3-’~C]serine 
(55 mCi/mmol) were obtained from Amersham International. 
Restriction endonucleases and DNA-modifying enzymes were 
purchased from New England Biolabs and Amersham Interna- 
tional. Blue-Sepharose, CM-Sephadex and Sephacryl S-200 
were obtained from Pharmacia Fine Chemicals. All other bio- 
chemicals used in this study were obtained from Sigma Chemi- 
cal Company. H,-folate was prepared by the method of Hatefi 
et al. [21]. The oligonucleotides were synthesized by Bangalore 
Genei Private Ltd., (Bangalore, India). Centricon filters were 
from Amicon Inc. 
Bacterial strains and growth conditions. E. coli strain 
DH5a (BRL) was the recipient for all the plasmids used in sub- 
cloning. The BL21(DE3), BL21(DE3) pLysS strains [22] were 
used for the bacterial expression of pETSH and deletion clones. 
Luria-Bertani medium or terrific broth with 50 pg/ml of ampicil- 
lin was used for growing E. cnli cells containing the plasmids 
WI. 
DNA manipulations. Plasmids were prepared by the alka- 
line lysis procedure as described by Sambrook et al. [23]. Re- 
striction endonuclease digestions, Klenow filling and ligations 
were performed according to the manufacturer’s instructions. 
The preparation of competent cells and transformation were per- 
formed by the method of Alexander et al. [24]. From the agarose 
gel, the DNA fragments (> 200 bp) were eluted by Gene Clean 
I1 Kit (Bio 101), <200 bp in size by Mermaid Kit (Bio 101) or 
by low-melting agarose gel method [23]. 
Construction of N and C-terminal deletion clones. A com- 
mon vector for the expression of mutant clones was prepared by 
the following method. PET-3c vector [25] has two NheI sites. 
To make a unique NheI site which is next to the ATG, the second 
NheI site was removed by deleting a 200-bp fragment by EcoRV 
digestion and self ligation. This vector was designated as PET- 
3e. The PET-3e plasmid was digested with NheI, Klenow-filled, 
then cut with BarnHI and gel purified as described in the previ- 
ous section. 
pETSH expression construct 1111 was used for all the DNA 
manipulations. This pETSH clone was cleaved by NdeI, KpnI 
and BamHI into two fragments i.e. a 1.26-kb KpnI-BamHI as 
constant fragment and a 230-bp of NdeI-KpnI as variable frag- 
ment. For convenient handling, the NdeI- KpnI insert size was 
increased by releasing the insert either with SphI- EcoRI 
(560 bp) or BglII-EcoRI (350 bp). The SphI-EcoRI and 
BglII-EcoRI fragments were gel purified and used for further 
modifications. The SphI-EcoRI fragment has an unique AvaII 
site at position 45 bp from the ATG codon. To obtain a 14- 
amino-acid deletion clone, the SphI- EcoRl fragment was di- 
gested with AvaII, Klenow filled followed by KpnI digestion. 
This AvaII-KpnI 180-bp fragment along with KpnI-BamHI 
1.26-kb constant fragment was ligated to PET-3e vector at 
BamHI and end-filled NheI sites. This construct was designated 
as pSN2 (414). Similarly, a BglII-EcoRI 370-bp fragment was 
used in the construction of pSN3 (430) and pSN4 (449) deletion 
clones. In order to obtain a large N-terminal deletion ( 4 7 3 ,  
pETSH was digested with Acc651, Klenow filled, followed by 
the BarnHI digestion. This 1.26-kb end-filled Acc65I -BamHI 
fragment was cloned into the BarnHI and end-filled NheI sites 
of PET-3e vector (designated as pSN6). pSC2 (4185) C-terminal 
deletion clone was constructed by cloning the BglII-StuI 1.0- 
kb fragment at the BglII and end-filled XbaI sites of pETSH 
vector. Two oligonucleotides were designed, namely SHPl a (5’ 
TG GCA CCC AGA GAT GCC GAT 3’) primer for a six amino- 
acid deletion (excluding Metl) and SHPlb (5’ TG GCT GTT 
CTG GAG GCC CTA 3’) primer for a 58-amino-acid deletion 
(excluding Metl). PCR was performed using Vent DNA poly- 
merase as described in New England Biolabs product specifica- 
tions with the following modifications. For a 100-p1 reaction, 
10 ng pETSH plasmid, 0.15 pM of each primer (SHPla and 
SHMl [ I l l )  and 0.4 mM of each dNTP were used. The sample 
was incubated in a thermal cycler (MJ Research) at 94°C for 
4 min then kept for 25 cycles of amplification. Each cycle in- 
cluded I-min denaturation (94”C), I-min annealing (50°C) and 
1.5-min chain elongation (72°C). After 25 cycles, the reaction 
was extended for an additional 5 min at 72°C. The 1.43-kb PCR 
product was gel purified from the agarose gel. This product was 
digested with KpnI and the 210-bp fragment was gel purified 
and cloned at KpnI and end-filled NdeI sites of pETSH vector, 
designated as pSNl (46). Similarly the PCR was performed 
using SHPlb and SHMl primers and the 1.30-kb PCR product 
was gel purifiei. This was digested with KpnI and the 52-bp 
fragment was cloned at the KpnI and end-filled NdeI sites of 
pETSH vector, designated as pSN5 (458). The clone pSCl 
(449) was constructed by using SHPla and SHM2 (5’ TACAG, 
GATCCTAGATCTGCAGGGTCA 3’) with a stop codon at 
435th amino acid followed by a BamHI site, as primers. The 
cloning junctions and the presence of deletion for all the above 
deletion clones were confirmed by restriction enzyme digestions 
and DNA sequencing [26]. 
Expression of N- and C-terminal deletion clones in BL21 
(DE3) pLysS. BL21(DE3) pLysS strain with the deletion con- 
structs, pETSH, PET-3e plasmids were grown in 25 ml Luria- 
Bertani medium containing 50 lg/ml of ampicillin and induced 
by addition of (0.3 mM) isopropyl 1-thio-P-galactopyranoside. 
The total, soluble and insoluble extracts were analyzed on SDS/ 
PAGE [27]. 
Protein sequencing. The expressed proteins were analyzed 
on SDS/PAGE and transferred to a Hybond Poly(viny1idene 
difluoride) membrane. The proteins were stained with Ponceau 
S and the appropriate bands were cut out, loaded on to a Shi- 
madzu gas-phase sequenator PSQl to determine the N-terminal 
sequence of the mutant proteins [28]. 
Purification of sheep liver cytosolic recombinant SHMT 
(rSHMT), des-(Al-K6)-SHMT and des-(Al-W14)-SHMT 
enzymes. pETSH, pSNl and pSN2 plasmids were transformed 
into BL21 (DE3) pLysS strain. A single colony was inoculated 
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in 50 ml Luria-Bertani medium containing 50 pg/ml ampicillin 
and grown overnight at 37°C. 4% of the cells were inoculated 
into 1 1 terrific broth media containing 50 pg/ml ampicillin. Af- 
ter 3.5 h of growth at 37"C, the cells were induced for 4 h with 
0.3 mM isopropyl 1-thio-P-galactopyranoside. The cells were 
harvested and the cell pellet was resuspended in 150 ml extrac- 
tion buffer (50 mM potassium phosphate, pH 7.4, 5 mM 2-mer- 
captoethanol, 1 mM EDTA and 100 pM pyridoxal-P). The cell 
suspension was left at room temperature for 1 h and sonicated 
until it was optically clear. The sonicate was centrifuged at 
27000Xg for 20 min. The supernatant was subjected to 25- 
65 % ammonium sulfate fractionation, blue-Sepharose and Seph- 
acryl S-200 column chromatography as described earlier [ l l ] .  
The active Sephacryl S-200 fractions were pooled and subjected 
to 0-65 % ammonium sulfate precipitation. The pellet obtained 
was resuspended in buffer A (50 mM phosphate, pH 7.4, 1 mM 
2-mercaptoethanol, 1 mM EDTA) and extensively dialyzed 
against 3 1 of the same buffer (with two changes) for 16 h. The 
dialyzed sample was used as the enzyme in these studies. 
The determination of the isoelectric point (PI value) for 
rSHMT, des-(Al-K6)-SHMT and des-(A1 -W14)-SHMT 
helped us in the design of a new purification protocol for the 
rSHMT and des-(A1 -Wl4)-SHMT. The new protocol involved 
the use of CM-Sephadex instead of blue-Sepharose as reported 
earlier [ l l ] .  The crude extracts for rSHMT and des-(A1 -W14)- 
SHMT were prepared as described before. The crude extracts 
were subjected to 0-65 % ammonium sulfate precipitation, the 
pellet obtained was resuspended in 20 ml 20 mM potassium 
phosphate, pH 6.4, 1 mM 2-mercaptoethanol, 1 mM EDTA and 
50 pM pyridoxal-P and then dialyzed for 24 h against the same 
buffer (1 1 with two changes). The dialyzed sample was centri- 
fuged at 27000Xg for 10 min and the supernatant was loaded 
on to a CM-Sephadex column (2X20cm) which was equili- 
brated with 20 mM potassium phosphate, pH 6.4, 1 mM 2-mer- 
captoethanol, 1 mM EDTA and 50 pM pyridoxal-P. The column 
was washed with same buffer ( I  1) and the bound enzyme was 
eluted with 100 ml200 mM potassium phosphate, pH 7.4, 1 mM 
2-mercaptoethanol, 1 mM EDTA and 50 pM pyridoxal-P. The 
eluted sample was subjected to 0-65% ammonium sulfate pre- 
cipitation. The pellet obtained was resuspended in 4 ml 200 mM 
potassium phosphate, pH 7.4, 1 mM 2-mercaptaethano1, 1 mM 
EDTA, 50 pM pyridoxal-P and subjected to Sephacryl S-200 
column chromatography as described earlier [ 1 I]. Fractions con- 
taining enzyme were pooled and precipitated at 65 % ammonium 
sulfate and the pellet was resuspended in buffer A and dialyzed 
against 1 1 of the same buffer (with two changes) for 16 h and 
this enzyme preparation was used in  these studies. 
Enzyme assay. SHMT activity was assayed using [ 3 - T ]  
serine and H,-folate as substrates [29, 301. One unit (U) was 
defined as the amount of enzyme catalyzing the production of 
1 pmol HCHO . min-' at 37°C. Proteins were analyzed on a 
6% non-denaturing PAGE. SHMT activity staining was per- 
formed using /I-phenylserine as substrate [31]. Protein was esti- 
mated using BSA as a standard [321 for the determination of the 
specific activity. 
Isoelectric focussing. Isoelectric focussing was performed 
on 5% polyacrylamide gel plates between pH 3.5-10, at 
2000 V, 50 mA and 30 W according to the manufacturer's in- 
structions (Pharmacia Fine Chemicals). The gel was calibrated 
with the standard marker proteins (PI 3.5-10). The purified 
rSHMT, des-(A1 -K6)-SHMT and des-(A1 -W14)-SHMT sam- 
ples were applied (20 pl of 1.5 mg/ml) on the gel. The proteins 
were fixed in 10% trichloroacetic acid and stained with Coomas- 
sie brilliant blue R-250 after subjecting to isoelectrofocussing. 
Circular dichroism. Circular dichroic (CD) measurements 
were made in Jasco-J-500 A automated recording spectropolari- 
meter. All CD spectra were recorded at 22 2 2°C in buffer A 
using the same buffer as blank. Far-ultraviolet CD studies were 
performed at a protein concentration corresponding to 0.1 A2R0 
unit/ml (where 1 A,,,, unit is the amount giving an absorbance 
of 1 at 280 nm in 1 nil solution in a 1-cm light path). The CD 
spectra obtained were plotted as molar ellipticity assuming a 
relative subunit molar mass of 52900 g/mol for the rSHMT, 
52319 g/mol for des-(Al-K6)-SHMT and 51 622 g/mol for 
des-(A1 -W14)-SHMT. The subunit molar masses were calcu- 
lated from their respective amino acid sequences. OM, = 
(Bm"XM)/cXd where Omo = observed ellipticity, M = subunit 
molar mass, c = concentration of protein in mg/ml and d = path 
length in dm. 
Visible CD spectra were recorded in a Jasco-J-20 C auto- 
mated recording spectropolarimeter. The protein concentration 
corresponding to 1 A,,, unit/ml in buffer A was used. The molar 
absorption coefficients for rSHMT, des-(A1 - K6)-SHMT and 
des-(A1 -W14)-SHMT were calculated from the amino acid se- 
quence by the method of Gill and von Hippel [33] as 
168325.2 M-' cm-', 178968.8 M-' cm I, 145320.5 M-' cm-', 
respectively ; the concentration of these proteins was calculated 
using the absorption coefficients. 
Inactivation of the SHMTs by heat and urea. rSHMT, des- 
(A1 -K6)-SHMT and des-(A1 -W14)-SHMT (125 pg/ml) were 
incubated in buffer B (50 mM potassium phosphate pH 7.4, 
1 mM 2-mercaptoethanol, 1 mM EDTA, 50 pM pyridoxal-P) at 
50°C or 55°C. The aliquots (10 pl) were withdrawn at 0, 5, 10 
and 15 min, cooled to 0°C and assayed for residual enzyme ac- 
tivity (301. They were also incubated at 12.5 pg/ml in buffer B 
with urea (0-2 M) at 3022°C for 2 h. An aliquot (80 pl) of 
this reaction mixture was used directly for enzyme assay by the 
addition of ~-[3-'~C]serine (10 pl) and H,-folate (10 pl) [30]. 
Thermal denaturation studies. The thermal denaturation of 
rSHMT, des-(A1 -K6)-SHMT and des-(Al-W14)-SHMT was 
performed in a Gilford Response I1 spectrophotometer from Ms. 
Ciba Corning Diagnostics, as described by Bhaskar et al. [7] 
with the following modifications. The protein samples (250 pl 
of 0.3 mg/ml) in buffer A were heated from 30°C to 80°C at 
the rate of 1 "C/min using the software built into the instrument. 
The absorbance change in each case was monitored at 287 nm 
and data averaged from two experiments. The first derivative of 
the thermal denaturation profiles was used to evaluate the appar- 
ent transition temperatures of the three proteins. Similar condi- 
tions were used to monitor the thermal denaturation profiles of 
rSHMT and des-(A1 -W14)-SHMT in  the presence of serine, 
glycine and alanine (I00 mM) and pyridoxal-P (50 pM) using 
the buffer blank in the reference cuvette with the same ligand 
concentration. 
Apoenzyme preparation. Apoenzymes of rSHMT, des- 
(A1 -K6)-SHMT and des-(A1 -W14)-SHMT were prepared as 
described earlier 1341 with minor modifications. D-Alanine 
(200 mM) was added to the holoenzyme (1 mg/ml) in 50 mM 
potassium phosphate pH 7.4, 10 mM 2-mercaptoethanol, 1 mM 
EDTA, 200 mM ammonium sulfate and incubated at 37°C for 
4 h. The pyruvate and pyridoxamine 5'-phosphate (pyridox- 
amine-P) formed during the reaction were removed by passing 
the sample through a 30-kDa Centricon filter. 
Size-exclusion chromatography. To determine the native 
molecular mass of rSHMT, des-(A1 - K6)-SHMT and des-(A1 - 
W14)-SHMT, a Superose 6 HR 10/30 analytical gel filtration 
column was used on a Pharmacia FPLC system. The column 
was calibrated with the standard proteins apoferritin (440 kDa), 
sheep cytosolic SHMT (21 3 kDa), yeast alcohol dehydrogenase 
(1 50 kDa), bovine serum albumin (66 kDa), carbonic anhydrase 
(29 kDa) and cytochrome c (12.4 kDa). The buffer used for this 
study was buffer A containing 0.1 M KCl. 
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Fig. 1. The SDSRAGE analysis of the expressed proteins of N- and 
C-terminal deletion clones of SHMT. Aliquots equivalent to 0.15 and 
0.25 A,,,,, units of E. coli cells were used for the analysis of total and 
soluble proteins, respectively. Lanes 1 and 24, molecular mass markers; 
lane 2, total protein and lanes 3 and 22 soluble proteins of PET-3e; lane 
4, total protein and lanes 5 and 23, soluble proteins of pETSH; lanes 6, 
8, 10, 12, 14, 16, 18, 20 total proteins and lanes 7, 9, 11, 13, 15, 17, 19, 
21 soluble proteins of pSN1, pSN2, pSN3, pSN4, pSN5, pSN6, pSCl 
and pSC2, respectively. The gels were stained with Coomassie brilliant 
blue R-250. 
The molecular masses of the holo, apo and reconstituted ho- 
loenzymes of these proteins were determined on calibrated TSK- 
G 3000 SW gel filtration column connected to Shimadzu LC6A 
HPLC instrument with an on-line ultraviolet detector (SPD 
6AV). The tetrameddimer percentages were calculated by using 
area normalization method on HPLC-Chromatopac CR6A and 
the amount of sample in each peak was expressed as a percent- 
age of the total. The column was equilibrated with buffer A 
containing 0.1 M KCI. 
RESULTS 
Construction and overexpression of N- and C-terminal dele- 
tion clones of SHMT. Using restriction enzyme and PCR-based 
methods, plasmids pSNl (A6), pSN2 (414), pSN3 (430), pSN4 
(A49), pSNS (ASS), pSN6 (475) representing N-terminal dele- 
tions and pSCl (449), pSC2 (4185) of C-terminal deletions in 
the cDNA clone of sheep cytosolic SHMT were constructed. 
Restriction enzyme digestions and DNA sequencing of these 
clones confirmed the presence of appropriate deletion, ribosome 
binding site (Shine Dalgarno sequence), start (ATG) and stop 
(TAG) codons in all the deletion clones. 
As shown in  Fig. 1, des-(A1 -K6)-SHMT (lane 7) and des- 
(Al-W14)-SHMT (lane 9) were present in  the soluble extract. 
Although the expressed protein in the case of des-(A1 -RSS)- 
SHMT (lane 14), des-(A1 -G7S)-SHMT (lane 16), des-(Q43S- 
F483)SHMT (lane 18) and des-(L299-F483)-SHMT (lane 20) 
were present in the total extract, it could not be detected in the 
soluble fraction (lanes IS, 17, 19 and 21, respectively). These 
proteins were present in  the insoluble fraction. The insoluble 
extracts were also enzymatically inactive. Unlike these mutant 
proteins, des-(Al-V30)-SHMT (lanes 10, 11) and des-(Al- 
L49)-SHMT (lanes 12, 13) were not present at detectable levels 
in any of the fractions and were barely detectable on western 
blots. 
Protein sequencing. N-terminal amino acid sequencing showed 
that deletions of 6, 14, 58 and 75 amino acids had occurred in 
the protein expressed by pSN1, pSN2, pSNS and pSN6 clones, 
respectively (Table 1). It can be seen that des-(Al-W14)- 
SHMT and des-(A1 -G7S)-SHMT had two additional amino 
acids (Ala-Arg) at the N-terminus compared to their expected 
deletions. These additional amino acids were derived from the 
vector during subcloning as indicated by DNA sequencing of 
the pSNl and pSN6 clones. 
Enzyme purification and characterization. rSHMT, des-(A1 - 
K6)-SHMT and des-(A1 -Wl4)-SHMT were purified as de- 
scribed [ I l l  with the following modifications in the use of E. 
coli strain and growth medium. In this study, BL21(DE3) pLysS 
strain instead of BL21 (DE3) was used [ 1 I ]  as this strain facili- 
tated easy disruption of E. coli cells due to the presence of lyso- 
zyme. The terrific broth medium instead of Luria-Bertani me- 
dium was used for growing E. coli. The cells grown in 1 1 terrific 
broth yielded 40-SO mg purified protein compared to only 
10 mg protein from 1 1  Luria-Bertani medium. As shown in 
Fig. 2B, compared to rSHMT, des-(Al-K6)-SHMT had a 
greater mobility and des-(A1 -W14)-SHMT a lower mobility 
towards the anode on non-denaturing PAGE. The change in the 
net charge on the protein was confirmed by measuring the PI 
value by isoele Ztric focussing experiments, the values being 
6.85, 5.85 and 7.12, respectively. The information on the PI val- 
ues facilitated the standardization of the new protocol using CM- 
Sephadex at pH 6.4 for the purification of rSHMT and des- 
(A1 -W14)-SHMT. The enzymes thus purified were homogen- 
eous on non-denaturing PAGE, SDSPAGE (Fig. 2 )  and amino 
acid sequencing. des-(A1 -K6)-SHMT and des-(A1 -W14)- 
SHMT were able to perform H,-folate-dependent aldol cleavage 
of serine and H,-folate, independent reactions with p-phenyl- 
Table 1. N-terminal amino acid sequence of the deletion mutants of sheep liver cytosolic SHMT. 
Protein N-terminal amino acid sequence 
rSHMT 
Des-(Al-K6)-SHMT 
Des-(A1 -W14)-SHMT 
Des-(A1 -R5X)-SHMT 
Des-(A1 -G75)-SHMT 
MPVNKAPRDADLWSLHEK . . . . .  RAVLE . . . . .  EGYPGQ . . . . . . . . .  
1 I 15 59 76 
APRDADLWSLHEK . . . . .  RAVLE . . . . .  EGYPGQ . . . . . . . . . .  
I 15 59 I6 
ARSLHEK . . . . .  RAVLE . . . . .  EGYPGQ . . . . . . . . . .  
15 59 76 
AVLE . . . . .  EGYPGQ . . . . . . . . . .  
59 I6 
ARYPGQ . . . . . . . . . .  
76 
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Fig. 2. SDSRAGE and non-denaturing PAGE analysis of rSHMT, des-(Al-K6)-SHMT and des-(Al-W14)-SHMT. The proteins were purified 
as described in the Experimental Procedures. (A) SDSPAGE analysis. Lane 1, des-(Al-W14)-SHMT; lane 2, des-(Al-K6)-SHMT; lane 3 rSHMT; 
all 30 pg. The non-denaturing PAGE of rSHMT (50 pg; lane l), des-(Al-K6)-SHMT (50 pg; lane 2) and des-(Al-W14)-SHMT (45 pg; lane 3) 
in duplicate lanes was performed in 6% gels at 4°C for 30 h using 100 V current. A part of the gel (B) was stained with Coomassie and a second 
part (C) of the gel was stained for the enzyme activity as described in the Experimental Procedures. 
0 5 10 15 20 0 5 10 15 20 
Time (min) Time (min) 
Fig. 3. Thermal inactivation of rSHMT (O), des-(Al-K6)-SHMT (W) and des-(Al-W14)-SHMT (A). The three proteins (125 pglml) were 
incubated in buffer B at 50°C (A) or 55°C (B) for 5, 10, 15 min. Aliquots (10 pl) were withdrawn and immediately cooled to 0°C. The residual 
enzyme activity was assayed [30]. Activity at 0 time was normalized to 100%. 
serine and D-alanine as substrates. The enzymes were capable of 
forming 343-nm-absorbing geminal diamine, 425-nm-absorbing 
external aldimine and 495-nm-absorbing quinonoid spectral in- 
termediate species. Des-(A1 -K6)-SHMT (0.9 mM, 0.95 mM) 
and des-(A1 -W14)-SHMT (0.9 mM, 0.9 mM) had similar K,  
values for serine and H,-folate, respectively, compared to 
rSHMT (0.9 mM, 1.0 mM). They also had similar specific activ- 
ities, i.e. 5.2, 5.5 and 4.9 units/mg, respectively. There were no 
marked differences in the secondary structure between the three 
proteins as monitored by CD spectra in the range of 195- 
250 nm. 
Oligomeric structure. rSHMT, des-(A1 - K6)-SHMT and des- 
(A1 -W14)-SHMT proteins were subjected to chromatography 
on a Superose-6 HR 10/30 analytical gel filtration column, as 
described in Experimental Procedures and the native molecular 
mass of these proteins was calculated from a plot of relative 
elution volume versus the log (molecular mass) of standard pro- 
tein markers. The values obtained were 225 m a ,  213 kDa and 
190 kDa, respectively. These results suggested all these enzymes 
are homotetramers. 
Temperature stability studies. rSHMT, des-(A1 - K6)-SHMT 
and des-(A1 -W14)-SHMT (125 pg/ml) were incubated at 50°C 
and 55°C for 0, 5 ,  10 and 15 min and the residual enzyme activ- 
ity was determined. It is evident from Fig. 3 A that incubation at 
50°C for 15 min, resulted in a minimal loss of activity of 
rSHMT and des-(A1 -K6)-SHMT, whereas des-(A1 -W14)- 
SHMT lost > 50% activity under similar conditions. When the 
temperature was increased to 55 "C, the latter lost all its activity 
(within 5 min), whereas the other two retained more than 80% 
of their activity at this time interval, although increasing periods 
of incubation at 55°C resulted in a progressive loss of activity 
(Fig. 3 B). 
The thermal denaturation profile of the three enzymes 
showed that while rSHMT and des-(A1 - K6)-SHMT behaved 
similarly, the midpoint of denaturation curve for des-(A1 - 
W14)-SHMT was at lower temperature. The apparent melting 
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Fig.4. Effect of urea on the oligomeric structure and activity of 
rSHMT (O), des-(Al-K6)-SHMT (W) and des-(Al-W14)-SHMT 
(A). All the enzymes (12.5 pg/ml) were incubated in buffer B at urea 
concentrations indicated in the figure for 2 h at 30 2 2°C. Aliquots 
(80 pl) were withdrawn and assayed for residual activity by addition of 
10 pl each of 36 mM ~-[3- '~C]serine and 18 mM H,-folate as described 
[30]. The enzyme activity determined in the absence of urea served as 
a control and this activity was normalized to 100%. 
Table 2. Thermal stability of rSHMT and des-(Al-W14)-SHMT in 
the presence of ligand. The apparent melting points were determined 
from the first derivative plots of the denaturation curves (see text for 
details). 
Ligand Concn Apparent melting point 
rSHMT des-(Al-W14)- 
SHMT 
mM " C  
56 52 
Serine 100 65 56 
Glycine 100 58 55 
D- Alanine 100 56 51 
Pyridoxal-P 0.05 58 54 
- 
temperatures values calculated from the first derivative plot were 
56"C, 55°C and 52°C for rSHMT, des-(Al-K6)-SHMT and 
des-(A1 - W14)-SHMT, respectively. It was observed that serine 
has a significant effect on the thermal stability of SHMT and 
shifted the enzyme from an 'open' to a 'closed' form, whereas 
other ligands such as threonine, alanine, etc., had no significant 
effect [7, 351. it was therefore essential to compare the effect of 
the ligands on the thermal denaturation of these three proteins. 
Serine (100 mM) enhanced the apparent melting temperature 
from 56 to 65°C for rSHMT, whereas it increased only from 
52°C to 56°C for des-(Al-W14)-SHMT. Other ligands such as 
glycine (100 mM), D-ahine (100 mM) and pyridoxal-P 
(50 pM) caused either marginal increase or no change (Table 2). 
Denaturation of rSHMT, des-(Al-K6)-SHMT and des- 
(Al-W14)-SHMT with urea. Urea-induced inactivation of 
these three proteins was performed as described in Experimental 
Procedures. Enzyme activity was measured after incubation with 
various concentrations of urea (0-2 M). The mid points of the 
inactivation for rSHMT, des-(A1 -K6)-SHMT and des-(A1 - 
W14)-SHMT were 1.820.1 M, 1.720.1 M and 1.220.1 M, re- 
spectively (Fig. 4). 
12 U 16 182022 12 U 16 182022 
ELUTION VOLUME (ml) 
12 I4 16 182022 
Fig. 5. Size-exclusion chromatography of holo, apo and reconstituted 
holo enzymes of rSHMT (left), des-(Al-K6)-SHMT (middle) and 
des-(Al-W14)-SHMT (right). All the enzyme forms (300 pg/ml) in 
buffer A were chromatographed on a TSK-G 3000 size-exclusion chro- 
matography column attached to Shimadzu LC6A HPLC instrument with 
an on-line ultraviolet detector (SPD 6AV). The column was equilibrated 
with buffer A containing 0.1 M KC1. The same buffer was passed 
through the column at a flow rate of 1 ml/min. The elution profiles are 
shown in the figure. Peak I and peak I1 correspond to tetramer and dimer 
of SHMT, respectively. 
The role of pyridoxal-P on the oligomeric structure of 
rSHMT, des-(Al-K6)-SHMT and des-(Al-W14)-SHMT. 
The apoenzymes were prepared by incubating the proteins with 
D-alanine (200 mM) for 4 h at 37°C followed by Centricon 
filtration to remove pyridoxamine-P and pyruvate formed in the 
reaction. All three apoenzymes had no catalytic activity. The 
addition of pyridoxal-P (100 pM) to the apoenzymes resulted in 
the regain of 96% and 94% activity for rSHMT and des-(Al- 
K6)-SHMT, respectively. However, only 22% of the activity of 
des-(A1 - W14)-SHMT was regained and increasing the concen- 
tration of pyridoxal-P to 1 mM did not increase the activity of 
the reconstituted protein. The oligomeric status of the three holo, 
apo and reconstituted holoenzymes were examined using TSK- 
G 3000 gel filtration column. As shown in Fig. 5 ,  all three holo- 
enzymes were present predominantly in the tetrameric form with 
elution volumes of 14.0 ml, 14.2 and 14.7 ml, respectively; how- 
ever, the apoenzymes of rSHMT, des-(A1 -K6)-SHMT were 
present as a mixture of tetramers (75% and 65%, respectively) 
and dimers, while the apoenzyme of des-(Al- W14)-SHMT was 
present predominantly as a dimer (95 %). When pyridoxal-P 
(100 pM) was added to all the apoenzymes, rSHMT, and des- 
(A1 -K6)-SHMT were present as >96% and 92% tetramer, re- 
spectively, while des-(A1 - W14)-SHMT was only partially 
(20 %) converted to tetramer. 
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Fig.6. Visible CD spectra of holo, apo and reconstituted holo en- 
zymes of rSHMT (A) and des-(Al-W14)-SHMT (B). The protein con- 
centration corresponding to 1 A?,,, unit/ml in buffer A was used for re- 
cording spectra i n  Jasco-J 20C Spectropolarimeter. (-) Holo, 
(-. - .  -) apo and (---) reconstituted holoenzymes. 
Additional evidence for the role of the N-terminal region in 
maintaining the tetrameric structure of the enzyme as indicated 
by the ability to form a schiff’s base at the active site was moni- 
tored by measuring visible CD spectra. It is evident from 
Fig. 6 A  that the recombinant enzyme has the characteristic CD 
spectra with maximum ellipticity at 425 nm. The apoenzyme 
gave baseline ellipticity in the region 350-500 nm. Reconstitu- 
tion of apoenzyme with pyridoxal-P yielded a holoenzyme prep- 
aration with a CD spectrum identical to that of the native holo- 
enzyme. However, the apoenzyme of des-(A1 -W14)-SHMT 
could only be partially reconstituted with pyridoxal-P (Fig. 6B).  
DISCUSSION 
The mammalian SHMT which is a homotetramer has been 
extensively characterized with respect to its catalytic mechanism 
[2 ,  5, 61. However, there is little information available on the 
subunit interactions and stability of this tetrameric enzyme. 
Earlier in our laboratory, the cDNA for sheep cytosolic SHMT 
was cloned, overexpressed in E. coli and the physico-chemical 
as well as kinetic properties of the purified protein studied [ 111. 
The availability of this clone facilitated an in-depth examination 
of the structure function relationship of the enzyme. As a first 
step in this direction, several clones with specified stretches of 
amino acids deleted at the N and C-termini were constructed 
and these enabled us to assign a role, if any, for these residues 
in catalysis, folding and assembly of the subunits of the enzyme. 
Using restriction-enzyme-based methods, pSN2, pSN3, pSN4, 
Table 3. Properties of apo, reconstituted holoenzymes of rSHMT, 
des-(Al-K6)-SHMT and des-(Al-W14)-SHMT. The holoenzymes 
had similar specific activities (4-5 units/mg, see text for details), were 
essentially in tetrameric form and exhibited characteristic maximum CD 
at 425 nm. These values were normalized to 100. The values given in 
the table are expressed as a percentage of their respective holoenzyme 
values. The three apoenzymes were catalytically illactive (< 1 % com- 
pared to holoenzyme) and had negligible CD at 425 nm. 
Enzyme Property Value for 
rSHMT des- des- 
(Al-  (Al- 
K6)- W14)- 
SHMT SHMT 
5% 
Apoenzy me tetramer I 5  65 <4 
dimer 25 35 >95 
Reconstituted holo tetramer >96 >92 20 
dinier <3 <s 80 
visible CD (42.5 nm) 98 96 20 
SHMT activity 96 94 22 
pSN6 and pSC2 deletion clones were constructed. pSN1, pSNS 
and pSC3 were constructed by PCR method in which Vent DNA 
polymerase was used for the PCR amplifications to limit errors 
during amplification. 
Under the experimental conditions described in Experimen- 
tal Procedures, pSNl and pSN2 were able to express soluble 
and catalytically active enzymes, similar to pETSH (Fig. 1). The 
low level of expression seen with pSN3 and pSN4 could be due 
to the possible secondary structure in the mRNA at the ribosome 
binding site and start codon [36, 371, or alternatively the deleted 
proteins des-(A1 -V30)-SHMT and des-(A1 -L49)-SHMT, 
might be unstable and therefore could not be detected on the 
SDYPAGE gels. The expressed des-(A1 -R58)-SHMT, des- 
(A1 -G75)-SHMT, des-(Q435-F483)-SHMT and des-(L299- 
F483)-SHMT mutant proteins were present predominantly in the 
insoluble fraction (Fig. I). The deletion of 14 N-terminal amino 
acids does not affect the enzyme activity, while deletion of a 
large number of amino acids from N and C-terminus resulted in 
the expression of proteins in the insoluble fraction. 
Studies with porcine AAT revealed that the N-terminal re- 
gion was involved in the inter subunit interactions [17]. The 
availability of the des-(A1 -K6)-SHMT and des-(Al- W14)- 
SHMT facilitated an examination of the role of amino acids 1 - 
14 in the subunit interactions and maintenance of oligomeric 
structure. Together with rSHMT, the enzymes were purified to 
homogeneity with a yield of 40-50 mg/l. The specific activity 
of rSHMT (4.9 U/mg) isolated in this study was comparable to 
the value reported earlier [ I l l .  In addition to performing the 
physiological reaction, the mutant proteins were capable of 
using /I-phenylserine as a substrate (Fig. 2 C) thereby demon- 
strating their ability to perform H,-folate-dependent as well as 
independent reactions. 
A unique feature of the mutant enzymes was the significant 
change in their electrophoretic mobility on non-denaturing 
PAGE (Fig. 2B)  and PI values. A comparison of the N-terminal 
sequences of the mutant enzymes (Table 1) showed that in des- 
(Al-K6)-SHMT one Lys (Lys 6) was deleted increasing the 
overall net negative charge, whereas, in des-(A1 -W14)-SHMT 
one Lys, Arg and two Asp were removed and one Arg was added 
due to vector fusion, resulting in an increase in the overall net 
positive charge. These results indicated that the N-terminus in 
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SHMT contributed to the net charge carried by the enzyme. A 
comparison of the retention volumes of rSHMT, des-(A1 -K6)- 
SHMT and des-(Al-W14)-SHMT (15.0 ml, 15.1 ml and 
15.2 ml, respectively) suggested that removal of the N-terminus 
resulted in a change in the hydrodynamic volume of des-(A1 - 
W14)-SHMT which is evidently less thermostable than the other 
two proteins (Fig. 3). It was observed that the ligands like serine 
convert the enzyme from an ‘open’ to a ‘closed’ form. One of 
the consequences of this change is the increased thermal stability 
of the enzyme. While the thermal stability of the rSHMT 
increased from 56°C to 65”C, upon the addition of serine, this 
change was only marginal (52°C to 56°C) with des-(A1 -W14)- 
SHMT. Another criterion employed for the conversion of open 
to closed form is the aldol cleavage of serine which is supposed 
to occur only in the closed form [35].  The K,,, and V,,,, values 
of des-(Al-W14)-SHMT were similar to those of rSHMT in- 
dicative of the fact that it was as capable as rSHMT in perform- 
ing serine aldol cleavage. These observations taken together sug- 
gest that des-(A1 -W14)-SHMT can be converted from an 
‘open’ to ‘closed’ form and the absence of increased thermal 
stability in the presence of serine could be due to the deletion 
of the N-terminal arm. It is interesting to recall that in the case of 
porcine cytosolic AAT, a deletion of 9 amino-terminal residues 
resulted in the large decrease i n  the thermal stability [17]. Dena- 
turation with urea is another convenient monitor of stability of 
the enzyme and it is evident that the concentration of urea re- 
quired for 50% inactivation of the des-(A1 -Wl4)-SHMT is low 
compared to rSHMT and des-(A1 -K6)-SHMT (Fig. 4). The re- 
sults strongly implicate the N-terminal 14 amino acids in the 
stabilization of the tetrameric SHMT. 
Pyridoxal-P has been implicated in the maintenance of the 
oligomeric structure of sheep liver SHMT [12]. In view of the 
decreased stability of des-(Al - W14)SHMT compared to 
rSHMT, it was necessary to examine the relationship between 
the N-terminal arm and pyridoxal-P in the stabilization of the 
tetrameric SHMT structure. Removal of pyridoxal-P from the 
rSHMT and des-(A1 -K6)-SHMT holoenzymes resulted in  par- 
tial dissociation of the tetramer to dimers. Immediate reconstitu- 
tion with pyridoxal-P resulted in 90-95% recovery of enzyme 
activity and the formation of the tetramer (Fig. 5). The good 
correlation between the recovery of the enzyme activity, visible 
CD spectra (Fig. 6) and the tetramer concentration strongly sug- 
gested that the tetramer with bound pyridoxal-P is the enzymati- 
cally active form of the enzyme (Table 3). In the absence of 
pyridoxal-P which stabilizes the tetrameric SHMT, des-(A1 - 
W 14)-SHMT dissociated completely to diniers unlike rSHMT 
and des-(A1 -K6)-SHMT. Addition of pyridoxal-P to apo des- 
(A1 - W14)-SHMT resulted in reconstitution to active tetrameric 
species only partially ( ~ 2 0 % ;  Table 3). These results suggest 
that amino acid residues 7-14 are probably involved in dimer- 
dimer interactions. The presence of charged residues in this 
stretch suggests possible ionic interactions. The results presented 
in this paper provide evidence for the architecture of mammalian 
SHMT as a dimer of dimers and that this oligomeric structure 
is stabilized not only by the cofactor (pyridoxal-P) but also by 
the N-terminal arm of the protein. 
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